# Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

> **NCT03001817** · PHASE3 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 551 (actual)

## Conditions studied

- Severe Hypertriglyceridemia

## Interventions

- **DRUG:** K-877
- **DRUG:** Fenofibrate
- **DRUG:** Placebo (for K-877)
- **DRUG:** Placebo (for Fenofibrate)

## Key facts

- **NCT ID:** NCT03001817
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-28
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-06-24
- **Target enrollment:** 551 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03001817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03001817, "Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03001817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*